Dengue Virus Envelope Protein Domain III Antigens
The Native Antigen Company now provides Envelope protein Domain III antigens for all four Dengue virus serotypes. These antigens are suitable for use in immunoassay development for diagnostic and vaccine research.
Discount on Pertussis Toxin for the Remainder of 2019
The Native Antigen Company manufactures native Pertussis toxin for a range of applications, including highly specific antibody capture systems to monitor vaccination programmes. Click on the link below to find out more about our 2019 discount.
Fluorescent Labelling Kits for Bacteria Visualisation
The Native Antigen Company now offers Legionella and Gram-negative bacteria labelling kits. These kits allow for specific detection and enrichment of culturable bacteria using click chemistry, and the use of fluorescent reporters, purification tags or magnetic beads.
About The Native Antigen Company
The Native Antigen Company specialises in the development and manufacture of native and recombinant viral and bacterial antigens, antibodies and immunoassays, as well as bespoke product development and custom manufacturing. The company has decades of experience in producing high-quality proteins with its proprietary mammalian cell expression system to ensure correct glycosylation and proper folding. The Native Antigen Company’s high-quality reagents are widely adopted by leading pharmaceutical, in vitro diagnostic assay manufacturers, and academic groups in cutting-edge vaccine research and serology, where correct folding and glycosylation are vital.